Embase™
Subject
Coverage
• Alternative medicine
• Biological science relevant to human
medicine
• Biochemistry
• Biomedical engineering and medical
instrumentation
• Biotechnology
• Clinical and experimental medicine
• Drugs
• Environmental science
File Type
Bibliographic
Features
Thesaurus
Controlled Term (/CT)
Alerts (SDIs)
Weekly (default) or biweekly
CAS Registry
®
Number Identifiers

Page Images

STN AnaVist™
Keep & Share


SLART


STN Easy
Learning Database
•
•
•
•
•
•
•
•
•
•
Structures
Forensic science
Hospital management
Industrial medicine
Medical devices
Occupational hygiene
Pediatrics
Pharmacy
Pharmacology and drug therapy
Pharmaco-economics
Public health
®
®
Record
Content
• Bibliographic information
• Controlled terms (Emtree drug and medical descriptors)
• Drug trade names and their manufacturers
• Medical device trade names and manufacturers (1998 to the present)
• Approximately 80% of the records include abstracts
• CAS Registry Numbers
File Size
More than 31.2 million records (01/2016)
Coverage
1947 to the present
Updates
Daily with about 4,000 records
Language
English
Database
Producer
In North America:
Elsevier B.V.
Bibliographic Databases
360 Park Avenue South
New York, NY 10010-1710
Phone: 212-989-5800
Fax:
212-633-3990
Email:
usembaseinfo@elsevier.com
In Europe and Rest of World
(outside Japan):
Elsevier B.V.
E-products Team
Radarweg 29
Amsterdam 1043 NX
Netherlands
Phone: (+31) 20 485 3911
Fax:
(+31) 20 485 2912
Email:
ebd-marketing@elsevier.com


In Japan:
Elsevier B.V.
Bibliographic Databases
1-9-15 Higashi-Azabu
Minato-ku Tokyo 106-0044
Japan
Phone: (+81)-3-5561-5031
Fax:
(+81)-3-5561-5046
Email:
jpembaseinfo@elsevier.com
January 2016
2
Embase
Sources
About 7,600 journals from about 70 countries (approximately 95% of file)
Books, conference proceedings, and reports (approximately 5% of file)
User Aids
Online Helps (HELP DIRECTORY lists all help messages available)
STNGUIDE
Embase Journal List is available at: http://www.embase.com/info/
Emtree Thesaurus (updated three times per year)
Clusters
• ALLBIB
• AUTHORS
• BIOSCIENCE
• CASRNS
• COMPANIES
• CORPSOURCE
• ENVIRONMENT
• FORMULATIONS
• HEALTH
• MEDICINE
• MEETINGS
• PHARMACOLOGY
• PV
• TOXICOLOGY
STN Database Clusters information (PDF).
Pricing
Enter HELP COST at an arrow prompt (=>).
January 2016
3
Embase
Search and Display Field Codes
The fields that allow left truncation are marked with an asterisk (*).
Search Field Name
Search
Code
Display
Codes
Search Examples
Basic Index * (contains single words
from the title (TI), abstract (AB),
controlled term (CT), chemical name
(CN), corporate name (CO), name of
product (NP), and gene number
(GEN) fields, as well as CAS
Registry Numbers)
None
(or /BI)
S STOMACH ULCER
S 51481-61-9
S FOOD(1W)DRUG ADMINISTR?
S ?SPRAY?
AB, CN, CO,
CT, GEN, NP,
RN, TI
Abstract *
/AB
AB
Accession Number
/AN
Author (includes editor) (6)
/AU
Chemical Name (Drug or Medical
Device Trade Name) (1,2)
Chemical Name Segment *
Clinical Trial Numbers
/CN (or /TN)
Controlled Term (contains Medical
Descriptors, Drug Descriptors,
including major terms) (3)
/CT
Corporate Name (Manufacturer)(2,4)
/CO
Corporate Source (4,6)
Country of Publication (ISO code and
text)
Digital Object Identifier
/CS
/CY
S IMAGING STUD?/AB
S ?PHYSEM?/AB
S 85114254/AN
S 2005469912/AN
S 20151000029/AN
S JONES, E A/AU
S O REILLY?/AU
S TAGAMET/CN
S NEMBUTAL/CN (L) LABAZ/CO
S THIOGLYCOLATE/CNS
S NCT00004730/NCT
S ISRCTN78047760/NCT
S STOMACH ULCER/CT (L) DT/CT
S *STOMACH ULCER/CT
S LINDANE+ALL/CT
S CISPLATIN/CT (L) IT/CT
S PANCREAS DISEASE/CT
S ANIMAL EXPERIMENT/CT AND L1
S CALBIOCHEM/CO
S RESEARCH BIOCHEMICALS/CO
S UNIV ARIZ?/CS
S FRANCE/CY
S JP/CY
S 10.1016/J.FCT.2013?/DOI
S 25368387/DN
S CONFERENCE/DT
S C/DT
S SANDHOFF@UNI-BONN.DE/EML
S SANDHOFF DE/EML
S L1 AND ED>20041100
S 20130430/ED.FIR
DN
DT
S L1 and EDAL>20091231
S L2 AND AB/FA
S 016/FS
S CANCER/FS
S MEDLINE/FS
S A02168/GEN
S LANCAO/ISN
S 0388-6107/ISN
S J CARD SURG/JT
S JOURNAL OF CARDIAC SURGERY/JT
S L1 AND EN/LA
S 20090925/MD
S INSULIN/MT
S NORWAY/ML
S ASTELLAS/MO
S 2009/MY
ED
Not displayed
FS
Document Number
Document Type (code and text)
Email Address (4)
/CNS
/NCT
/DOI (or
/FTDOI)
/DN
/DT
(or /TC)
/EML
Entry Date (5,8)
Entry Date First Appeared in Embase
or Embase Alert (EMBAL) (5,7)
Entry Date MEDLINE (5,8)
Field Availability
File Segment (code and text)
/ED
/ED.FIR
Gene Number
International Standard (Document)
Number (ISBN, ISSN, CODEN)
Journal Title (contains full and
abbreviated title)
Language (ISO code and text)
Meeting Date
Meeting Information
Meeting Location
Meeting Organizer
Meeting Year
/GEN
/ISN
/EDAL
/FA
/FS
/JT
/LA
/MD
/MT
/ML
/MO
/MY
AN
AU, SO
CN
NCT
CT
CO
CS
CY
FTDOI, DOI
CS, EML
ED
ED.FIR
GEN
ISN, SO
JT, JTA, JTF,
SO
LA
MD, SO
MT, SO
ML, SO
MO, SO
MY, SO
January 2016
4
Embase
Search and Display Field Codes (cont’d)
Search
Code
Search Field Name
Name of Product
Publication Date (5)
Publication Year (5)
Publisher
Publisher Item Identifier
Source (contains abbreviated journal
title, publication date, collation
information (volume, issue,
pagination, and number of
references), meeting information,
ISSN, ISBN, and CODEN)
Summary Language (ISO code and
text)
Supplementary Terms*
Title *
Update Date (5,9)
Update Date MEDLINE (5,9)
Display
Codes
Search Examples
/NP
/PD
/PY
/PB
/PUI
/SO
S ACUSON 128?/NP
S 20040100-20050600/PD
S 2003-2004/PY
S ELSEVIER IRELAND/PB
S “S 0001-706X(96)00022-8”/PUI
S HEMATOL PATHOL/SO
S (1011-6788 AND 2004)/SO
NP
PD, SO
PY, SO
PB
PUI
SO
/SL
S L3 AND EN/SL
SL
/ST
/TI
/UP
/UPAL
S HIPPOCAMPUS/ST
S AMINO ACID#/TI
S UP20050119
S L1 and UPAL>20091231
ST
TI
ED
ED
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
Medical device trade names are available from 1998 to the present.
For data after mid-1998, you can use the (L) operator to link the trade names in /CN to manufacturer names in /CO.
An online thesaurus is available in this field.
Search with implied (S) proximity is available in this field.
Numeric search field that may be searched with numeric operators or ranges.
Use (L) to link AU CS pairs.
Only added to Embase records that have been added or updated after April 29, 2013.
ED is the entry date for Elsevier-created Embase records and specifically excludes records from the MEDLINE file segment. EDAL is
used for the entry date of Embase records plus MEDLINE file segment records.
(9) UP is the update date for Elsevier-created Embase records and specifically excludes records from the MEDLINE file segment. UPAL
is used for the update date of Embase records plus MEDLINE file segment records.
Limiting Search Codes
Only an L-number for an answer set created in Embase may be limited.
Search
Code (1)
Search Field Name
Animal subject
English language records
Female subject
Human subject
Major descriptor
Male subject
/NONHUMAN
/ENGLISH
/FEMALE
/HUMAN
/MAJOR
/MALE
Search Examples
S L4/NON
S L1/MAJ,ENG (2)
S L3/FEM
S L1/HUM
S L1/MAJ (3)
S L2/MAL
(1) The code may be abbreviated to the first three letters.
(2) An answer set may be limited to more than one subject area.
(3) Major terms may be searched directly in the Controlled Term (/CT) field by preceding the search term with an asterisk, e.g., S *LUNG
EMBOLISM/CT.
Super Search Fields
Enter a super search code to execute a search in one or more fields that may contain the desired information.
Super search fields facilitate crossfile and multifile searching. EXPAND may not be used with super search
fields. Use EXPAND with the individual field codes instead.
Search
Code
Search Field Name
Index Terms
January 2016
/IT
Fields
Searched
/CT, /ST
Search Examples
S ANIMAL EXPERIMENT/IT
Display
Codes
CT, ST
5
Embase
Controlled Term (/CT) Thesaurus
All relationship codes may be used with both the SEARCH and EXPAND command in the Controlled Term
(/CT) thesaurus.
Code
ALL
AUTO (1)
BT
HIE
KT
NOTE
NT
PFT
STD
UF
USE
Content
All associated terms
(BT, SELF, QA, TYPE, NTYP, HNTE, RN, EC, UF, NT)
Automatic Relationship
(SELF, USE)
Broader Terms
(BT, SELF)
Hierarchy (Broader and Narrower Terms)
(BT, SELF, NT)
Keyword Terms (multiword phrases containing term)
(SELF, KT)
Notes associated with the term
(SELF, NOTE, HNTE, RN, EC)
Narrower Terms
(SELF, NT)
Preferred Terms and Synonyms
(SELF, USE, UF)
Standard (Broader and Narrower Terms)
(BT, SELF, NT)
Used For (Synonyms) (Forbidden Terms)
(SELF, UF)
Use (Preferred Terms)
(SELF, USE)
Example
E JOINT INJURY+ALL/CT
E LINDANE+ALL/CT
E ARTICULAR TRAUMA+AUTO/CT
E ANEURYSM+BT/CT
E MYOPATHY+HIE/CT
E LYMPHOMA+KT/CT
E VIRILIZATION+NOTE/CT
S STOMACH DISEASE+NT/CT
S SCLEROTHROMBOSIS+PFT/CT
S ALPHA AMYLASE + PFT/CT
E KIDNEY FAILURE+STD/CT
E ASPARAGINE+UF/CT
E ARTICULAR TRAUMA+USE/CT
(1) Automatic relationship is SET OFF. When SET REL is ON, the result of EXPAND without any relationship code is the same as
described for AUTO.
Thesaurus Field Descriptors
Code

BT
EC
HNTE (1)
KT
NT
NTYP (2)
QA
RN
TYPE (3)
UF
USE
Description
Self
Broader Term
Enzyme Commission Number
History Note
Keyword Term
Narrower Term
Term Name Type
Subheading abbreviation
CAS Registry Number
Term Type
Used For Term (Synonym)
Use (Preferred) Term
(1) Creation date for Preferred Terms, plus additional history notes. May also include scope notes describing how the Preferred Term is
indexed.
(2) Applies to Preferred Terms only. Three possible values: MeSH descriptor, device trade name or drug trade name.
(3) Disease term, drug term device term or medical term.
January 2016
6
Embase
DISPLAY and PRINT Formats
Any combination of formats may be used to display or print answers. Multiple codes must be separated by
spaces or commas, e.g., D L1 1-5 BIB ABS; D L1 TI,AU,SO,CS,AB. The fields are displayed in the order
specified.
Hit-term highlighting is available for all searchable fields. Highlighting must be ON during SEARCH to use the
HIT, HITIND, KWIC, and OCC formats.
Format
Content
Examples
AB
AN (1)
AU
AUPB (2,4)
CN (TN) (1)
CO (1)
CP (2)
CS
CT (1)
CY
DN (2)
DOI (FTDOI)
DT (TC)
ED (UP)
ED.FIR (1,2)
EML (2)
FS
FTDOI (2)
GEN (1)
ISN (2)
JT (2)
JTA (2)
JTF (2)
LA
MD (2)
ML
MO
MT
MY
NCT
NP (1)
PB
PD (2)
PUI
PY (2)
RN (1)
SL
SO
ST
TI (1)
Abstract
Accession Number
Author
Authors in Publication Order
Chemical Name (Drug Trade Name)
Corporate Name (Manufacturer)
Copyright MEDLINE (for unique MEDLINE records only)
Corporate Source
Controlled Term
Country of Publication (ISO names)
Document Number
Digital Object Identifier
Document Type
Entry Date (includes ED.FIR information when available)
Entry Date First Appeared in Embase or Embase Alert (EMBAL) includes ED (UP)
Email Address
File Segment
Digital Object Identifier
Gene Number
International Standard (Document) Number
Journal Title
Journal Title, Abbreviated
Journal Title, Full
Language
Meeting Date
Meeting Location
Meeting Organizer
Meeting Information
Meeting Year
Clinical Trial Numbers
Name of Product
Publisher
Publication Date
Publisher Item Identifier
Publication Year
CAS Registry Number
Summary Language
Source
Supplementary Terms
Title
D AB L4 1-5
D AN 1-15
D AU 5 6 8-10
D AUPB
D CN L1
D 1-6 L2 CO
D 1 AN CP
D CS L11
D CT 1-17
D 1-7 CY
D DN
D DOI or D FTDOI
D DT 4-18 L3
D ED, D UP
D ED.FIR
D EML
D FS 1-2
D DOI
D GEN
D 5,6 ISN
D JT
D JTA
D JTF
D LA 4 6 10
D MD
D ML
D MO
D MT
D MY
D NCT
D NP
D PB
D PD
D PUI
D JT PY
D RN 1-15 L2
D SL 1-5
D 5 L3 SO
D ST
D TI 50-70
ABS
ALL
AB
AN, TI, AU, CS, SO, DOI, PB, PUI, CY, DT, FS, NCT, LA, SL, ED (UP), AB, CT,
ST, RN, CN, NP, CO, GEN
AU, CS (grouped in pairs)
AN, TI, AU, CS, SO, DOI, PB, PUI, CY, DT, FS, NCT, LA, SL, ED (UP) (BIB is the
default)
AN, compressed bibliographic data
ALL, delimited for post-processing
AB, with text labels
ALL, indented with text labels
BIB, indented with text labels
CT, ST, RN, CN, NP, CO, GEN
D ABS 1-10
D ALL 5-10
AU.CS
BIB
CBIB
DALL
IABS
IALL
IBIB
IND (1)
January 2016
D AU.CS
D BIB 1-10
D CBIB
D DALL
D IABS
D IALL
D IBIB
D IND L2 1-10
7
Embase
DISPLAY and PRINT Formats (cont’d)
Format
Content
Examples
SCAN (1,3)
TRIAL (TRI,
FREE, SAM) (1)
TI, CT, ST, RN, CN, NP, CO, GEN (random display without answer numbers)
TI, CT, ST, RN, CN, NP, CO, GEN
D SCAN
D 1-3 TRIAL
HIT
HITIND (1)
KWIC
OCC (1)
Fields containing hit terms
IND
Hit term with 20 words on either side (KeyWord-In-Context)
Number of occurrences of hit terms and fields in which they occur
D HIT 5-10
D HITIND
D KWIC 1-3
D OCC 1-6
(1)
(2)
(3)
(4)
No online display fee for this format.
Custom display only.
SCAN must be specified on the command line, i.e., D SCAN or DISPLAY SCAN.
If 100 or more authors are provided, only the first 99 are presented followed by et al.
SELECT, ANALYZE, and SORT Fields
The SELECT command is used to create E-numbers containing terms taken from the specified field in an
answer set.
The ANALYZE command is used to create an L-number containing terms taken from the specified field in an
answer set.
The SORT command is used to rearrange the search results in either alphabetic or numeric order of the
specified field(s).
Field Name
Abstract
Accession Number
Author
Authors in Publication Order
CAS Registry Number
Chemical Name (Drug Trade Name)
Chemical Name and CAS Registry Number
Citation
Clinical Trial Numbers
CODEN
Controlled Term
Corporate Name (Manufacturer)
Corporate Source
Country of Publication
Document Number
Document Type
Email Address
Entry Date
Entry Date First Appeared in Embase or Embase Alert (EMBAL)
Entry Date for MEDLINE
File Segment
Genbank Number
Gene Number
International Standard Book Number
International Standard (Document) Number
International Standard Serial Number
Journal Title
Journal Title, Abbreviated
Journal Title, Full
Language
Meeting Date
Field Code
AB
AN
AU
AUPB
RN
CN (TN)
NAME
CHEM
CIT
NCT
CODEN
CT
CO
CS
CY
DN
DT
EML
ED
ED.FIR
EDAL
FS
GENBANK
GEN
ISBN
ISN
ISSN
JT
JTA
JTF
LA
MD
ANALYZE/
SELECT (1)
Y
Y
Y
Y (9)
Y (2)
Y
Y (2)
Y (2)
Y (3,4)
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y (2)
Y
N
Y (5)
N
Y
Y (6)
Y (6)
Y
Y
SORT
N
N
Y
N
N
Y
N
N
N
Y
Y
N
Y
Y
Y
Y
Y
N
Y
Y
N
Y
N
Y
Y
N
Y
Y
Y
Y
Y
Y
January 2016
8
Embase
SELECT, ANALYZE, and SORT Fields (cont’d)
Field Name
Meeting Information
Meeting Location
Meeting Organizer
Meeting Year
Name of Product
Occurrence Count of Hit Terms
Publication Date
Publication Year
Publisher Item Identifier
Source
Summary Language
Supplementary Terms
Title
Trade Name
Treatment Code
Update Date
Update Date for MEDLINE
Field Code
MT
ML
MO
MY
NP
OCC
PD
PY
PUI
SO
SL
ST
TI
TN
TC
UP
UPAL
ANALYZE/
SELECT (1)
Y
Y
Y
Y
Y
N
Y
Y
Y
Y (7)
Y
Y
Y (default)
Y
Y (8)
Y
Y
SORT
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
N
Y
Y
Y
N
N
(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g., SEL HIT
RN.
(2) Appends /BI to the terms created by SELECT.
(3) SELECT HIT and ANALYZE HIT are not valid with this field.
(4) Extracts the first author, publication year, volume, and first page with a truncation symbol appended and /RE appended to the terms
created by SELECT.
(5) Selects or analyzes ISSN, ISBN, and CODEN with /ISN appended to the terms created by SELECT.
(6) Appends /JT to the terms created by SELECT.
(7) Selects or analyzes ISSN, ISBN, and CODEN with /SO appended to the terms created by SELECT.
(8) Appends /DT to the terms created by SELECT.
(9) Appends /AU to the terms created by SELECT.
Sample Records
DISPLAY IALL
ACCESSION NUMBER:
TITLE:
AUTHOR:
CORPORATE SOURCE:
AUTHOR:
CORPORATE SOURCE:
SOURCE:
DIGITAL OBJECT ID:
PUBLISHER:
PUBLISHER IDENT.:
COUNTRY:
DOCUMENT TYPE:
FILE SEGMENT:
LANGUAGE:
January 2016
2014213313 EMBASE
Full-text
Saussurea lappa alleviates inflammatory chemokine
production in HaCaT cells and house dust mite-induced
atopic-like dermatitis in Nc/Nga mice.
Lim, Hye-Sun; Ha, Hyekyung; Lee, Mee-Young; Jin, Seong-Eun;
Jeong, Soo-Jin; Jeon, Woo-Young; Shin, Na-Ra; Shin,
Hyeun-Kyoo
Herbal Medicine Formulation Research Group, Korea Institute
of Oriental Medicine, Daejeon 305-811, Korea, Republic of.
hkshin@kiom.re.kr
Lim, Hye-Sun; Jeon, Woo-Young; Sok, Dai-Eun
(correspondence)
College of Pharmacy, Chungnam National University, Daejeon
305-764, Korea, Republic of. daesok@cnu.ac.kr
Food and Chemical Toxicology, (2014 January 2014) Vol. 63,
pp. 212-220.
Refs: 31
ISSN: 0278-6915; E-ISSN: 1873-6351 CODEN: FCTOD7
10.1016/j.fct.2013.10.050
Elsevier Ltd.
S 0278-6915(13)00725-4
United Kingdom
Journal; Article
013
Dermatology and Venereology
029
Clinical and Experimental Biochemistry
030
Clinical and Experimental Pharmacology
037
Drug Literature Index
English
9
Embase
SUMMARY LANGUAGE:
ENTRY DATE:
English
Entered Embase: 9 Apr 2014
Last Updated on Embase: 9 Apr 2014
First Entered Embase or Embase Alert: 2 Apr 2014
ABSTRACT:
Saussurea lappa is a traditional herbal medicine used for to treat various
inflammatory diseases. In this study, we investigated the protective
effects of S. lappa against atopic dermatitis using human keratinocyte HaCaT
cells, murine mast cell line MC/9 cells, and a house dust mite-induced atopic
dermatitis model of Nc/Nga mice. Treatment with the S. lappa caused a
significant reduction in the mRNA levels and production of inflammatory
chemokines and cytokine, including thymus- and activation-regulated chemokine
(TARC), macrophage-derived chemokine (MDC), regulated on activation, normal
T-cell expressed and secreted (RANTES), and interleukin-8 (IL-8) in tumor
necrosis factor-α/interferone-γ-stimulated HaCaT cells. S. lappa
exhibited the significant reduction in histamine production in MC/9 cells. In
the atopic dermatitis model, S. lappa significantly reduced the dermatitis
score and serum IgE and TARC levels. In addition, the back skin and ears of S.
lappa-treated Nc/Nga mice exhibited reduced histological manifestations of
atopic skin lesions such as erosion, hyperplasia of the epidermis and dermis,
and inflammatory cell infiltration. In conclusion, an extract of S. lappa
effectively suppressed the development of atopic dermatitis, which was closely
related to the reduction of chemokines and cytokine. Our study suggests that
S. lappa may be a potential treatment for atopic dermatitis.  2013.
CONTROLLED TERM:
CONTROLLED TERM:
Medical Descriptors:
animal cell
animal experiment
animal model
animal tissue
article
*atopic dermatitis: DT, drug therapy
back
cell infiltration
controlled study
cytokine production
dermis hyperplasia
disease severity
drug efficacy
ear
enzyme activation
enzyme regulation
enzyme repression
epidermis hyperplasia
histamine release
histopathology
*house dust mite induced atopic dermatitis: DT, drug
therapy
human
human cell
hyperplasia
in vitro study
male
mouse
nonhuman
protein analysis
protein blood level
rash
Drug Descriptors:
gamma interferon: EC, endogenous compound
immunoglobulin E: EC, endogenous compound
interleukin 8: EC, endogenous compound
macrophage derived chemokine: EC, endogenous compound
prednisolone
RANTES: EC, endogenous compound
*Saussurea lappa extract: DT, drug therapy
*Saussurea lappa extract: PD, pharmacology
January 2016
10
Embase
thymus and activation regulated chemokine: EC, endogenous
compound
tumor necrosis factor alpha: EC, endogenous compound
SUPPLEMENTARY TERM: Atopic dermatitis; Chemokines; Keratinocyte; Nc/Nga mice;
Saussurea lappa
CAS REGISTRY NO.:
(gamma interferon) 82115-62-6; (immunoglobulin E)
37341-29-0; (interleukin 8) 114308-91-7; (prednisolone)
50-24-8; (thymus and activation regulated chemokine)
181532-29-6
DISPLAY TRIAL
TI
Controlled multiplex PCR of enterotoxigenic Clostridium perfringens
strains in food samples.
CT
Medical Descriptors:
article
bacterial infection: DI, diagnosis
bacterium culture
clinical trial
*clostridium perfringens
controlled study
food
food contamination
*food poisoning: DI, diagnosis
gene
immunodiffusion
meat
nonhuman
nucleotide sequence
*polymerase chain reaction
priority journal
standard
CT
Drug Descriptors:
alpha toxin
ampli taq
bacterial DNA
DNA polymerase
enterotoxin
unclassified drug
RN
(DNA polymerase) 37217-33-7
CN
(1) ampli taq
CO
(1) Perkin Elmer (Germany)
NP
(1) ABI 373A; (2) ABI 380A
CO
(1) Applied Biosystems (Germany) ; (2) Applied Biosystems (Germany)
GEN EMBL M98037 referred number
DISPLAY of a Conference Review
AN
0050779249 EMBASE
TI
Abstracts Presented at the 31st Annual Meeting of the Arthroscopy
Association of North America.
SO
Arthroscopy - Journal of Arthroscopic and Related Surgery, (June 2012)
Vol. 28, No. 6, Supp. SUPPL. 1. Abstract Number: SS-01.
Meeting Info: 31st Annual Meeting of the Arthroscopy Association of North
America. Orlando, FL, United States. 17 May 2012-19 May 2012
ISSN: 0749-8063
PB
W.B. Saunders.
DT
Journal; Conference; (Conference Review)
FS
CONF
LA
English
ED
Entered STN: Sep 2012
Last Updated on STN: Sep 2012
AB
The proceedings contain 77 papers. The topics discussed include: arthroscopic
treatment of labral tears in acetabular dysplasia: the role of the tonnis angle and its
effect on the outcomes; osteoplasty for cam type impingement is more accurate when
performed open than arthroscopic; traction injury risk in hip arthroscopy-duration or
amount? an intraoperative nerve monitoring study; arthroscopic iliopsoas tendon release
January 2016
11
Embase
in the treatment of internal snapping hip; hip arthroscopy in the older patient; full
arthroscopic TFCC repair: seven years experience and comparison of two methods;
arthroscopic wrist debridement and radial styloidectomy for late-stage scapholunate
advanced collapse wrist; arthroscopic tennis elbow release: outcomes correlated to
associated lesions; arthroscopic tennis elbow release: outcomes correlated to associated
lesions; and osteochondral lesions of the talus: a ten-year prospective clinical
experience.
EXPAND in /CT field (Subheadings included)
=> E LUNG EMBOLISM/CT
E#
FREQUENCY
AT
TERM
-------------E1
E2
E3
E4
E5
E6
E7
E8
E9
E10
E11
E12
23
1
23854
4
5231
5809
223
14
5032
706
1190
2380
LUNG
LUNG
27 --> LUNG
LUNG
LUNG
LUNG
LUNG
LUNG
LUNG
LUNG
LUNG
LUNG
EMBOLECTOMY/CT
EMBOLECTOMY: TH, THERAPY/CT
EMBOLISM/CT
EMBOLISM: CN, CONGENITAL DISORDER/CT
EMBOLISM: CO, COMPLICATION/CT
EMBOLISM: DI, DIAGNOSIS/CT
EMBOLISM: DM, DISEASE MANAGEMENT/CT
EMBOLISM: DR, DRUG RESISTANCE/CT
EMBOLISM: DT, DRUG THERAPY/CT
EMBOLISM: EP, EPIDEMIOLOGY/CT
EMBOLISM: ET, ETIOLOGY/CT
EMBOLISM: PC, PREVENTION/CT
EXPAND in /CT Thesaurus
=> E JOINT INJURY+ALL/CT
E1
0
BT5
emtree thesaurus/CT
E2
1
BT4
physical diseases, disorders and abnormalities/CT
E3
18
BT3
physical disease by anatomical structure/CT
E4
9649
BT2
musculoskeletal disease/CT
E5
8465
BT1
arthropathy/CT
E6
0
BT5
emtree thesaurus/CT
E7
1
BT4
physical diseases, disorders and abnormalities/CT
E8
3
BT3
physical disease by etiology and pathogenesis/CT
E9
110813
BT2
injury/CT
E10
0
BT5
emtree thesaurus/CT
E11
1
BT4
physical diseases, disorders and abnormalities/CT
E12
18
BT3
physical disease by anatomical structure/CT
E13
9649
BT2
musculoskeletal disease/CT
E14
1667
BT1
musculoskeletal injury/CT
E15
1383
-->
joint injury/CT
HNTE Creation date 01 JAN 1984
E16
0
UF
articular trauma/CT
E17
0
UF
bone joint injury/CT
E18
0
UF
joint trauma/CT
E19
2404
NT1
ankle injury/CT
E20
99
NT2
ankle dislocation/CT
E21
1744
NT2
ankle fracture/CT
E22
524
NT3
malleolus fracture/CT
E23
621
NT3
talus fracture/CT
.....
In North America
CAS
STN North America
P.O. Box 3012
Columbus, Ohio 43210-0012 U.S.A.
CAS Customer Center:
Phone: 800-753-4227 (North America)
614-447-3700 (worldwide)
Fax:
614-447-3751
Email:
help@cas.org
Internet: www.cas.org
In Europe
FIZ Karlsruhe
STN Europe
P.O. Box 2465
76012 Karlsruhe
Germany
Phone: +49-7247-808-555
Fax:
+49-7247-808-259
Email:
helpdesk@fiz-karlsruhe.de
Internet: www.stn-international.com
In Japan
JAICI (Japan Association for
International Chemical Information)
STN Japan
Nakai Building
6-25-4 Honkomagome, Bunkyo-ku
Tokyo 113-0021, Japan
Phone: +81-3-5978-3601 (Technical Service)
+81-3-5978-3621 (Customer Service)
Fax:
+81-3-5978-3600
Email:
support@jaici.or.jp (Technical Service)
customer@jaici.or.jp (Customer Service)
Internet: www.jaici.or.jp
January 2016